Envoy Medical, Inc. (COCH) — Financial statements
Income statement, balance sheet, and cash flow for Envoy Medical, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.24↑7.1% | 0.23↓28.8% | 0.32↑33.3% | 0.24↓23.5% | 0.31 | |
| Cost of Revenue | 0.87↑17.8% | 0.74↓6.0% | 0.79↑58.4% | 0.50↓35.2% | 0.77 | |
| Gross Profit | -0.63↓22.4% | -0.52↓9.3% | -0.47↓81.2% | -0.26↑43.1% | -0.46 | |
| Operating Expenses | ||||||
| R&D Expenses | 12↑22.7% | 10↑13.7% | 9↑80.0% | 5↑26.3% | 4 | |
| General & Administrative Expenses | 8↑16.2% | 7↓6.0% | 7↑181.0% | 3↑4.5% | 2 | |
| Selling & Marketing Expenses | 1↓29.6% | 2↑4.1% | 2↑88.2% | 0.89 | 0.00 | |
| SG&A Expenses | 9↑6.9% | 9↓4.1% | 9↑157.3% | 3↑40.3% | 2 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 22↑15.5% | 19↑4.8% | 18↑111.8% | 8↑31.7% | 6 | |
| Total Costs & Expenses | 23↑15.6% | 19↑4.3% | 19↑108.8% | 9↑24.5% | 7 | |
| Operating Results | ||||||
| Operating Income | -22↓15.7% | -19↓4.9% | -18↓110.9% | -9↓26.7% | -7 | |
| Depreciation & Amortization | 0.30↑74.6% | 0.17↑30.1% | 0.13↑77.3% | 0.08↑5.6% | 0.07 | |
| EBITDA | -22↓10.9% | -20↑33.5% | -30↓245.1% | -9↓26.9% | -7 | |
| EBIT | -22↓11.5% | -20↑33.2% | -30↓243.7% | -9↓26.7% | -7 | |
| Interest & Other Income | ||||||
| Net Interest Income | -2↓94.9% | -0.82 | 0.00 | 0.00↓100.0% | 0.04 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 0.04 | |
| Interest Expense | 2↑94.9% | 0.82 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00↓100.0% | 0.72↓93.7% | 12 | 0.00 | 0.00 | |
| Other Income / Expenses | -1↑3.4% | -2↑86.7% | -12↓60.2% | -7↓300.1% | -2 | |
| Income Before Tax | -24↓14.2% | -21↑30.5% | -30↓87.9% | -16↓83.6% | -9 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -24↓14.2% | -21↑30.5% | -30↓87.9% | -16↓83.6% | -9 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -24↓14.2% | -21↑30.5% | -30↓87.9% | -16↓83.6% | -9 | |
| Bottom-Line Net Income | -24↑15.1% | -28↑10.5% | -31↓96.4% | -16↓49.2% | -11 | |
| EPS (Basic) | -1.23↑17.4% | -1.49↑41.3% | -2.54↓61.8% | -1.57↓49.5% | -1.05 | |
| EPS (Diluted) | -1.23↑17.4% | -1.49↑41.3% | -2.54↓61.8% | -1.57↓49.5% | -1.05 | |
| Weighted Average Shares | 20↑4.3% | 19↑49.7% | 13↑23.6% | 10↑0.0% | 10 | |
| Weighted Average Diluted Shares | 20↑4.3% | 19↑49.7% | 13↑23.6% | 10↑0.0% | 10 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.